Welcome

Albireo is an independent Swedish biotechnology company, which brings unique translational approaches to develop drugs that fulfil unmet medical needs in the gastrointestinal (GI) area. The team has a broad experience in drug development, primarily in the GI area and has an extensive network in the international scientific and clinical communities.

Latest News & Features

Albireo Appoints Dr Hans Graffner as Chief Medical Officer


2008-05-15